HBM BIOVENTURES CAYMAN LTD 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:19 pm Unchanged |
2024-09-30 | 13G | Mineralys Therapeutics, Inc. MLYS |
HBM BIOVENTURES CAYMAN LTD | 2,246,332 4.500% |
0 (Unchanged) |
Filing |
| 2024-02-13 4:09 pm Purchase |
2023-12-31 | 13G | Mineralys Therapeutics, Inc. MLYS |
HBM BIOVENTURES CAYMAN LTD | 2,246,332 5.500% |
2,246,332 (New Position) |
Filing |